Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | Director | August 10, 2026 | August 11, 2026 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,802 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Purchase · Acquired 5,000 · Balance 31,802 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 197,728 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 197,728 · Balance 197,728 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 21:53 UTC | KEMPER Corp KMPR · Entity 719 | PurchaseCommon Stock | 5,000 | $25.91 | $129,550.00 |
DisclosureSEC source: 0001208500-26-000004 · wk-form4_1786485214.xml · nonDerivative · entry 1 Gorevic Jason N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,802 Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:33 UTC | KEMPER Corp KMPR · Entity 719 | GrantCommon Stock | 4,730 | $32.77 | $155,002.10 |
DisclosureSEC source: 0001208500-26-000002 · wk-form4_1778272387.xml · nonDerivative · entry 1 Gorevic Jason N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,802 F1 · shares: Award of restricted stock units under the Kemper Corporation Second A&R 2023 Omnibus Plan ("Plan"), subject to forfeiture and other restrictions until vested pursuant to the Plan and the award agreement. Read SEC document |
| August 07, 2025 Filed Aug 7, 2025 16:43 UTC | KEMPER Corp KMPR · Entity 719 | PurchaseCommon Stock | 2,000 | $49.14 | $98,280.00 |
DisclosureSEC source: 0001208500-25-000003 · wk-form4_1754585014.xml · nonDerivative · entry 1 Gorevic Jason N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,072 Read SEC document |
| May 07, 2025 Filed May 8, 2025 20:23 UTC | KEMPER Corp KMPR · Entity 719 | GrantCommon Stock | 2,435 | $61.61 | $150,020.35 |
DisclosureSEC source: 0000860748-25-000144 · wk-form4_1746735772.xml · nonDerivative · entry 1 Gorevic Jason N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,072 F1 · shares: Award of restricted stock units based on a grant date value of $150,000 under the Kemper Corporation Amended and Restated 2023 Omnibus Plan ("Plan"), subject to forfeiture and other restrictions until vested pursuant to the Plan and the award agreement. Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:11 UTC | KEMPER Corp KMPR · Entity 719 | GrantCommon Stock | 2,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000860748-24-000153 · wk-form4_1714680652.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,637 F1 · shares: Award of restricted stock units based on a grant date value of $150,000 under the Amended and Restated Kemper Corporation 2023 Omnibus Plan ("Plan"), subject to forfeiture and other restrictions until vested pursuant to the Plan and the award agreement. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 197,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000075 · wk-form4_1710965517.xml · derivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,728 Underlying: Common Stock · 197,728 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 53,755 | $14.52 | $780,307.58 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 653,073 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 7,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 14 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,648 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F12 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 62,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 13 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,008 Underlying: Common Stock · 62,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 186,012 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 12 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,460 Underlying: Common Stock · 5,615 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 5,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,782 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,915 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F8 · derivative.expiration_date: On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 21,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,263 Underlying: Common Stock · 21,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 63,393 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 63,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · derivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,393 Underlying: Common Stock · 63,393 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,648 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 62,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,615 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 21,130 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000044 · wk-form4_1709672954.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,877 | $18.90 | $54,381.05 |
DisclosureSEC source: 0001477449-23-000101 · wk-form4_1701810368.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,734 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000101 · wk-form4_1701810368.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,075 Underlying: Common Stock · 5,615 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,615 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000101 · wk-form4_1701810368.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,864 | $22.89 | $65,568.42 |
DisclosureSEC source: 0001477449-23-000037 · wk-form4_1694031109.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,996 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000037 · wk-form4_1694031109.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,690 Underlying: Common Stock · 5,614 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,614 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000037 · wk-form4_1694031109.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| July 27, 2023 Filed Jul 28, 2023 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 10,000 | $30.03 | $300,303.00 |
DisclosureSEC source: 0001477449-23-000016 · wk-form4_1690574968.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 596,246 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2023. F2 · price: Represents the weighted average price of transactions ranging from $30.00 to $30.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,802 | $24.38 | $68,315.56 |
DisclosureSEC source: 0001415889-23-009195 · form4-06052023_080606.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 606,246 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009195 · form4-06052023_080606.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,304 Underlying: Common Stock · 5,614 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,614 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009195 · form4-06052023_080606.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 609,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 03, 2023 Filed May 4, 2023 20:28 UTC | KEMPER Corp KMPR · Entity 719 | GrantCommon Stock | 2,933 | $0.00 | $0.00 |
DisclosureSEC source: 0000860748-23-000101 · wf-form4_168323212238782.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,072 F1 · shares: Award of restricted stock units based on a grant date value of $130,000 under the Kemper Corporation 2023 Omnibus Plan ("Plan"), subject to forfeiture and other restrictions until vested pursuant to the Plan and the award agreement. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 186,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004415 · form4-03072023_090335.xml · derivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,012 Underlying: Common Stock · 186,012 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 22,040 | $25.91 | $571,078.44 |
DisclosureSEC source: 0001415889-23-004415 · form4-03072023_090335.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,434 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 16 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915 Underlying: Common Stock · 2,913 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F14 · derivative.exercise_date: On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F14 · derivative.expiration_date: On March 2, 2023, the reporting person earned 5,828 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 5,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 15 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,828 Underlying: Common Stock · 5,828 shares Expires not disclosed F11 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F12 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. F13 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. F13 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 5,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 14 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,782 Underlying: Common Stock · 5,782 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F10 · derivative.expiration_date: On March 2, 2022, the reporting person earned 17,346 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 7,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 13 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,648 Underlying: Common Stock · 7,648 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 22,944 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 12 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2022, the reporting person earned 7,784 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F8 · derivative.expiration_date: On March 2, 2022, the reporting person earned 7,784 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 15,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 11 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021 F7 · derivative.expiration_date: On March 2, 2021, the reporting person earned 46,430 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021 Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 10 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 27,311 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 8 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 7 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,648 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,891 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,131 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 15,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 589,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 8,262 | $25.36 | $209,540.84 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,660 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 22,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · derivative · entry 9 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,918 Underlying: Common Stock · 22,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 67,376 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 22,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004099 · form4-03032023_090302.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · balance_after: On March 19, 2021, the reporting person contributed 50,000 shares of TDOC common stock to the Jason N. Gorevic Grantor Retained Annuity Trust for the benefit of himself. Upon termination of the trust on June 6, 2022, 50,000 shares were previously distributed to the reporting person and continue to be reported in this Form 4 as directly owned. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 14:33 UTC | KEMPER Corp KMPR · Entity 719 | PurchaseCommon Stock | 3,000 | $43.00 | $129,000.00 |
DisclosureSEC source: 0000860748-22-000140 · wf-form4_165953716948622.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,139 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.